131 related articles for article (PubMed ID: 34811921)
1. Postchemotherapy tumor volume as a prognostic indicator in Wilms tumor: A single-center experience from South India.
Joseph LL; Boddu D; Srinivasan HN; Regi SS; Antonisamy B; John R; Mathew LG; Totadri S
Pediatr Blood Cancer; 2022 Feb; 69(2):e29454. PubMed ID: 34811921
[TBL] [Abstract][Full Text] [Related]
2. A higher tumor volume and undernutrition at diagnosis adversely affect the survival of children with Wilms tumor: A study of 200 patients.
Rahiman EA; Trehan A; Jain R; Menon P; Kakkar N; Srinivasan R; Sodhi KS; Saxena AK; Kapoor R; Bansal D
Pediatr Blood Cancer; 2022 Nov; 69(11):e29880. PubMed ID: 35841309
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
[TBL] [Abstract][Full Text] [Related]
4. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
5. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Groenendijk A; van Tinteren H; Jiang Y; de Krijger RR; Vujanic GM; Godzinski J; Rübe C; Schenk JP; Morosi C; Pritchard-Jones K; Al-Saadi R; Vaidya SJ; Verschuur AC; Ramírez-Villar GL; Graf N; de Camargo B; Drost J; Perotti D; van den Heuvel-Eibrink MM; Brok J; Spreafico F; Mavinkurve-Groothuis AMC
Eur J Cancer; 2022 Mar; 163():88-97. PubMed ID: 35042071
[TBL] [Abstract][Full Text] [Related]
6. Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies (2001-2020).
D'Hooghe E; Furtwängler R; Chowdhury T; Vokuhl C; Al-Saadi R; Pritchard-Jones K; Graf N; Vujanić GM
Cancer; 2023 Jun; 129(12):1930-1938. PubMed ID: 36929497
[TBL] [Abstract][Full Text] [Related]
7. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
[TBL] [Abstract][Full Text] [Related]
8. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.
Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA
Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.
Pasqualini C; Furtwängler R; van Tinteren H; Teixeira RAP; Acha T; Howell L; Vujanic G; Godzinski J; Melchior P; Smets AM; Coulomb-L'Hermine A; Brisse H; Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Graf N; Verschuur AC
Eur J Cancer; 2020 Mar; 128():38-46. PubMed ID: 32109849
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.
John R; Kurian JJ; Sen S; Gupta MK; Jehangir S; Mathew LG; Mathai J
J Pediatr Urol; 2018 Dec; 14(6):547.e1-547.e7. PubMed ID: 30017606
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.
Weirich A; Leuschner I; Harms D; Vujanic GM; Tröger J; Abel U; Graf N; Schmidt D; Ludwig R; Voûte PA
Ann Oncol; 2001 Mar; 12(3):311-9. PubMed ID: 11332141
[TBL] [Abstract][Full Text] [Related]
12. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of event-free survival in patients with Wilms tumor undergoing preoperative chemotherapy. Analysis of lymph-node yield in a single-center cohort.
Flores P; Cadario M; Strambach J; Sanjuanelo M; Saleme JM; Paz E; Cacciavillano W; Felizzia G; Galluzzo L; Corbetta JP
J Pediatr Urol; 2021 Apr; 17(2):227.e1-227.e5. PubMed ID: 33309612
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
[TBL] [Abstract][Full Text] [Related]
15. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.
Chagtai T; Zill C; Dainese L; Wegert J; Savola S; Popov S; Mifsud W; Vujanić G; Sebire N; Le Bouc Y; Ambros PF; Kager L; O'Sullivan MJ; Blaise A; Bergeron C; Mengelbier LH; Gisselsson D; Kool M; Tytgat GA; van den Heuvel-Eibrink MM; Graf N; van Tinteren H; Coulomb A; Gessler M; Williams RD; Pritchard-Jones K
J Clin Oncol; 2016 Sep; 34(26):3195-203. PubMed ID: 27432915
[TBL] [Abstract][Full Text] [Related]
16. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies.
Vujanić GM; D'Hooghe E; Graf N; Vokuhl C; Al-Saadi R; Chowdhury T; Pritchard-Jones K; Furtwängler R
Int J Cancer; 2021 Sep; 149(6):1332-1340. PubMed ID: 34109628
[TBL] [Abstract][Full Text] [Related]
18. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
Zekri W; Yacoub DM; Ibrahim A; Madney Y
J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372
[TBL] [Abstract][Full Text] [Related]
19. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience.
Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745
[TBL] [Abstract][Full Text] [Related]
20. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan.
Ghafoor T; Bashir F; Ahmed S; Khalil S; Farah T
J Pediatr Urol; 2020 Jun; 16(3):375.e1-375.e7. PubMed ID: 32224063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
